Emily Field
Stock Analyst at Barclays
(1.38)
# 3,640
Out of 5,140 analysts
7
Total ratings
66.67%
Success rate
-1.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Field
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Downgrades: Equal-Weight | n/a | $60.68 | - | 1 | Jul 30, 2025 | |
| GLPG Galapagos NV | Downgrades: Underweight | n/a | $33.50 | - | 1 | Jan 23, 2025 | |
| GSK GSK plc | Upgrades: Equal-Weight | n/a | $47.65 | - | 4 | Nov 5, 2021 | |
| ARGX argenx SE | Upgrades: Overweight | n/a | $809.64 | - | 1 | Oct 19, 2021 |
Novo Nordisk
Jul 30, 2025
Downgrades: Equal-Weight
Price Target: n/a
Current: $60.68
Upside: -
Galapagos NV
Jan 23, 2025
Downgrades: Underweight
Price Target: n/a
Current: $33.50
Upside: -
GSK plc
Nov 5, 2021
Upgrades: Equal-Weight
Price Target: n/a
Current: $47.65
Upside: -
argenx SE
Oct 19, 2021
Upgrades: Overweight
Price Target: n/a
Current: $809.64
Upside: -